Our Science & Lab
Based in Research & Investing in Clients
Celltex remains committed to leading the United States into the future of regenerative medicine through Mesenchymal Stem Cells (MSCs).
Our industry leadership and visionary approach continue to drive the company to improve the quality of life of thousands of individuals, with a concerted focus to make this therapy accessible to all in the near future.
The Science Behind the Art of Banking
Our state-of-the-art laboratory ensures the quality of each MSC product by isolating only the MSCs and, over the course of up to six weeks, growing the initial population to 200 million.
Once a client is ready for therapy, our laboratory staff prepares hundreds of millions of viable MSCs and sends them to certified and licensed physicians at Hospital Galenia to be administered.
Safety & Quality Control
CGMP & FDA Compliant
Our Houston, Texas-based, state-of-the-art laboratory meets or exceeds all Current Good Manufacturing Practices (cGMP) regulations and operates in full compliance with FDA guidelines. All Celltex operations are compliant with FDA guidelines and procedures.
All clients’ MSCs are cryogenically stored in the Celltex laboratory in Houston at -300º F in liquid nitrogen. Our advanced laboratory ensures the identity, strength and purity of each MSC product.
Curious about our facilities and techniques? We’d love for you to visit our laboratory in the Galleria area of Houston. Click below to contact a Client Service Coordinator and begin the process of scheduling your tour.Tour our Lab
Investing in the Future With Industry Partnerships
Celltex has begun the clinical trial process with esteemed medical and scientific institutions.
Alzheimer’s Disease Research
Partnership With Texas A&M University for a Multiyear Alzheimer’s Disease Research Study
We call the project “A Future to Remember,” and we are studying potential therapy using allogeneic MSC-derived exosomes with Texas A&M University.
Rheumatoid Arthritis & Osteoarthritis
Phase II B Wellness Protocol Clinical Study on Rheumatoid Arthritis and Osteoarthritis
Trial sponsor, in collaboration with Hospital Galenia, on a clinical trial authorized by COFEPRIS (Federal Commission for the Protection against Sanitary Risk), Mexico’s FDA equivalent.
Safety & Regulations
Committed to Leading the Future of Regenerative Medicine
Celltex is in compliance with regulations established by the FDA for banking and transporting MSCs. To meet the immediate needs of our clients, Celltex works with established, certified hospitals where highly qualified, licensed physicians make it possible for Celltex’s clients to receive their own MSCs for therapeutic purposes.
Currently, the FDA has not approved stem cells for commercial use if they have been expanded in large quantities; therefore, an individual may not use his or her own cells in the United States until clinical trials have been conducted.
Celltex has begun the clinical trial process with esteemed medical and scientific institutions. Following the conclusion of successful clinical trials, Celltex will seek approval from the FDA to provide stem cells for therapeutic use by physicians in the United States.
The Refreshing Power of Stem Cell Therapy
Until stem cell therapy is legalized in the United States, to meet the immediate needs of our clients, Celltex works with an established, certified hospital in Mexico where licensed physicians make it possible for Celltex’s clients to receive their own MSCs for therapeutic purposes.
We invite you to learn more about our internationally accredited partners at Hospital Galenia.
News & Information
Stay in the know about Celltex
Sign up to receive news, announcements, updates and offers about the latest happenings at Celltex.
I consent to the transfer and validation of my email address in conjunction with this email service, and I understand that I may withdraw my consent and unsubscribe at any time.